Context:

A former UCLA gynecologist, James Heaps, pleaded guilty to 13 felonies tied to the sexual abuse of five patients after an appeals court reversed his 2023 conviction over a trial fairness issue. The prior sentence of 11 years was preserved upon the guilty plea. The reversal came after a juror-related fairness dispute centered on a note from the foreman about English proficiency. UCLA has already agreed to nearly $700 million in settlements for hundreds of patients connected to the scandal, underscoring the broad fallout for the university. The plea signals a closing of a high-profile chapter and sets the stage for ongoing accountability and patient protections.”

Dive Deeper:

• Heaps was indicted in 2021 on multiple counts, including sexual battery by fraud, sexual exploitation of a patient, and sexual penetration of an unconscious person by fraudulent representation, with allegations spanning seven women from 2009 to 2018.

• In 2023, Heaps was convicted on five counts of sexual battery and penetration involving two patients and sentenced to 11 years in prison before the conviction was overturned by an appeals court in February due to concerns that the jury’s proceedings were not fairly shared with his defense because the foreman’s notes about a juror’s English proficiency were not disclosed.

• Rather than retrying the case on the original charges, Heaps pleaded guilty to 13 felonies involving five victims, and received the same 11-year prison sentence as the prior conviction.

• Heaps’ attorney, Leonard Levine, had suggested after the February reversal that exoneration could still be forthcoming, but did not respond to comment on the guilty plea.

• The 2019 scandal surrounding Heaps’ arrest led UCLA to settle hundreds of lawsuits for nearly $700 million, a record payout for a public university facing similar misconduct cases.

• Lawyer John Manly stated that the guilty plea and sentence send a clear message about consequences for violations of patients’ rights and dignity, reflecting the broader legal and reputational fallout for the university.

• The case now closes a controversial period in UCLA’s medical program history, with ongoing litigation and reforms likely shaping patient protection measures and medical oversight moving forward.